Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,857,579 papers from all fields of science
Search
Sign In
Create Free Account
Glucosidase Inhibitor
Any substance that inhibits glucosidase, specifically alpha-glucosidase in the brush border of the small intestines, an enzyme that catalyzes the…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots.
H. Kallwass
,
Cortney Carr
,
+8 authors
J. Keutzer
Molecular Genetics and Metabolism
2007
Corpus ID: 31393446
2006
2006
Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997–2003
Chi‐Wen Chiang
,
H. Chiu
,
C.-Y. Chen
,
H‐L. Wu
,
C.-Y. Yang
Journal of Clinical Pharmacy and Therapeutics
2006
Corpus ID: 1655018
Objective: To define the prescribing patterns of oral antidiabetic drugs (OADs) in Taiwan over a 7‐year period (1997–2003) and…
Expand
2006
2006
Effect of inhibition of alpha-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats.
Mitsuyoshi Yamamoto
,
M. Otsuki
Metabolism: Clinical and Experimental
2006
Corpus ID: 20171854
2005
2005
Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
S. Yamagishi
,
K. Nakamura
,
M. Takeuchi
Medical Hypotheses
2005
Corpus ID: 39939309
Review
2004
Review
2004
Biotechnology and molecular biology of the alpha-glucosidase inhibitor acarbose.
U. Wehmeier
,
W. Piepersberg
Applied Microbiology and Biotechnology
2004
Corpus ID: 45635404
The alpha-glucosidase inhibitor acarbose, O-[4,6-dideoxy-4[1 s-(1,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2-cyclohexen-1-yl…
Expand
2002
2002
Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.
M. Drent
,
A. Tollefsen
,
F. H. J. A. van Heusden
,
E. Hoenderdos
,
J. Jonker
,
E. van der Veen
Diabetes, Nutrition and Metabolism. Clinical and…
2002
Corpus ID: 19560395
AIMS A double-blind randomised study was performed to compare the dose-effect and dose-tolerability relationships between the…
Expand
2001
2001
Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor.
D. S. Lee
,
S. H. Lee
FEBS Letters
2001
Corpus ID: 39934662
Genistein is an isoflavone that is known to be contained in soybean. It was proved that genistein plays a pivotal role in…
Expand
Highly Cited
1996
Highly Cited
1996
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM
T. Hara
,
J. Nakamura
,
N. Koh
,
F. Sakakibara
,
N. Takeuchi
,
N. Hotta
Diabetes Care
1996
Corpus ID: 34865894
OBJECTIVE To examine the usefulness of α-glucosidase inhibitors in glycemic control of patients with NIDDM. The involvement of…
Expand
Highly Cited
1992
Highly Cited
1992
Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion.
N. Fukase
,
H. Takahashi
,
+6 authors
H. Sasaki
Diabetes Research and Clinical Practice
1992
Corpus ID: 3661238
Highly Cited
1987
Highly Cited
1987
Studies on the biosynthesis of the alpha-glucosidase inhibitor acarbose: valienamine, a m-C7N unit not derived from the shikimate pathway.
U. Degwert
,
R. van Hülst
,
+5 authors
H. Floss
Journal of antibiotics (Tokyo. )
1987
Corpus ID: 20859703
Feeding experiments with Actinoplanes sp. SN223/29 showed that 3-amino-5-hydroxy-[7-13C]benzoic acid is not incorporated into…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE